Medical Care Technologies Inc. develops and commercializes artificial intelligence applications across consumer software, imaging analysis, healthcare-oriented pre-screening and collectibles authentication. News about MDCE centers on its AI technology stack, including Snapshot Recipes, a mobile recipe application with AI-generated food and beverage content, and Real Game Used, a subsidiary developing a patent-pending AI authentication platform for sports memorabilia.
Company updates also cover AI imaging initiatives for dermatological analysis, wellness monitoring, product verification and automated quality control, as well as capital and asset-monetization activity through Infinite Auctions. Recurring announcements describe product redesigns, commercialization pathways, subsidiary activity, mobile-app user growth initiatives, and enterprise API or visual analytics use cases.
Medical Care Technologies (MDCE) completed another round of Snapshot Recipes optimizations and is rolling out new promotional campaigns this week.
The company says the update is designed to make its consumer AI cooking app faster and smoother. Campaigns focus on generating recipes from grocery or meal photos, with App Store and Google Play download prompts. No updated user counts or rankings were provided, and the announcement does not forecast downloads, revenue or user growth. Medical Care Technologies was debt free as of September 23, 2026.
Medical Care Technologies (OTCID:MDCE) detailed StrainScan Pro's agricultural configuration and demonstration activity as it looks toward its first enterprise clients.
The platform is live and is designed to analyze crop imagery for visible signs of disease, ripeness, pest damage, nutrient stress and yield irregularity. The field workflow compares images with earlier captures and routes alerts based on operator-defined thresholds. This announcement describes demonstration activity, not a signed customer contract or revenue forecast. StrainScan Pro is not a medical device.
Medical Care Technologies (MDCE) reported first-pass results from volunteer-image testing of its Melanoma Scan Beta workflow.
A substantial portion of the initial images met internal thresholds for focus, framing and visible-area isolation; images below those thresholds were excluded from mapping and comparison. Usable images were assigned to mapped body regions. Where more than one usable image covered the same mapped area, the platform completed side-by-side review. These are workflow findings, not clinical validation, performance benchmarks or diagnostic accuracy results. The company plans further evaluation passes as more volunteer images are collected.
Medical Care Technologies (MDCE) has moved its AI-assisted wound-monitoring application into structured internal testing of sequential wound images.
The tool is intended to let users capture smartphone photos of the same wound over time and review visible changes. Evaluation covers photo consistency, wound-boundary visualization, comparisons across sessions and whether the capture-and-review process can be repeated outside a clinic. The application remains in development. No product launch has been announced, and it has not received regulatory clearance.
The work uses the AI vision foundation also being tested in Melanoma Scan Beta, whose first volunteer-submitted image datasets are under internal review. The company was debt free as of September 23, 2026.
Medical Care Technologies (MDCE) reported it was debt free as of September 23, 2026, while continuing software development and demonstrations.
Its Melanoma Scan Beta has received its first human volunteer image datasets, which are under internal review. The platform remains in beta, has not received regulatory clearance and is not intended to diagnose or treat a medical condition. The wound-monitoring application remains in development. StrainScan Pro continues in enterprise demonstrations for agricultural and foodservice applications.
Subsidiaries Infinite Auctions and Real Game Used continue memorabilia transactions and photo-match authentication, including a recently completed first Fanatics / Topps supply-and-authentication cycle.
Medical Care Technologies (MDCE) has begun internal review of its first volunteer-submitted image datasets for the MDCE Melanoma Scan Beta application as part of its multi-phase testing protocol.
These initial human datasets follow the September 16 intake milestone and introduce real-world user conditions such as lighting, device type, distance, angle, image quality, and skin appearance beyond public dermatology archives. The review phase is testing three core functions: image intake through the beta workflow, placement on an interactive body map, and change-over-time visual comparison of mapped skin areas. Melanoma Scan Beta remains in beta development, has no regulatory clearance, and is not intended for diagnosis or treatment or as a substitute for professional medical evaluation.
Medical Care Technologies (MDCE)/b) reported that subsidiaries Infinite Auctions and Real Game Used have completed the first executed transaction under the previously disclosed Fanatics / Topps arrangement. Infinite Auctions sold game-worn sports memorabilia to Topps for use in Topps sports trading card products, while Real Game Used provided photo-match authentication for the supplied items.Fanatics’ collectibles division powered by Topps generated about $1.6 billion in revenue in 2024 and has been described as tracking toward more than $2 billion in 2025, with expectations approaching $3 billion in 2026. Medical Care Technologies describes the completed supply-and-authentication cycle as a commercial proof point for its subsidiaries, but the company emphasizes that this initial transaction does not include guarantees of additional volume, future purchase commitments, or specific revenue levels.
Medical Care Technologies (MDCE) has launched the first presentation of its StrainScan Pro AI vision platform in restaurant service, moving from a planning phase on September 18, 2026 to an executed kitchen workflow demonstration.
The software, already used in agricultural quality applications, is now shown to restaurant operators as an iPad Air-based inspection pipeline across three stations: receiving, staging, and pass. Each station uses the same sequence of image capture, contextual indexing, visual analysis versus expected appearance, and exception routing. The company stresses that this is a first-time vertical demonstration and not a commercial contract award, and that StrainScan Pro is an enterprise visual analysis tool rather than a medical device.
Medical Care Technologies (MDCE) is preparing its first StrainScan Pro demonstration tailored for restaurant service, adapting its existing enterprise AI vision platform from agricultural use to kitchen workflows. The demo will follow a three-station inspection path covering receiving, staging/prep hold, and the pass station, where incoming produce, prepped items, and finished plates are visually analyzed on-device using iPad Air. Each capture is indexed to station and lot, run through category-specific visual analysis modules, and exceptions are routed for hold or secondary review to help reduce product waste, remakes, and margin loss. The company stresses this is a demo in preparation, not a commercial contract.
Medical Care Technologies (MDCE) reports receipt of its first human volunteer image datasets for internal testing of the MDCE Melanoma Scan Beta platform. This follows the August 31 call for volunteers and marks a move beyond earlier work that relied on public dermatology archives such as HAM10000, ISIC collections, and TCIA melanoma cohorts. The new images introduce real‑world conditions, including varied lighting, device types, distances, angles, image quality, and skin appearances. The datasets will be used to evaluate image intake, body‑map organization, and longitudinal comparison of the same skin areas over time. The AI‑assisted application remains in beta, has no regulatory clearance, and is not intended for diagnosis, treatment, or disease prevention.